Switzerland remains a leading global location for innovation, research and high-value investment. While its direct tax incentives are more limited than some peers, the country offers a highly skilled workforce, strong public funding support and a world-class innovation ecosystem. This makes it particularly attractive for life sciences, advanced technology and multinational R&D operations.
Overview
Switzerland remains one of Europe’s most innovative economies, supported by strong research institutions, a highly skilled workforce and a stable fiscal and legal environment. Its innovation framework is decentralised, combining cantonal tax incentives, federal grant support and a well-developed private funding ecosystem.
For businesses, the system is most relevant where R&D, IP development or scale-up investment can be anchored in Switzerland’s cantonal regimes or aligned with Innosuisse and related public programmes.
1. Cantonal tax incentives
Switzerland’s main tax-based innovation tools sit at cantonal and communal level. Following the TRAF reforms, many cantons offer an R&D super-deduction, a patent box regime and, in some cases, tax holidays or negotiated relief for new or expanding businesses.
The R&D super-deduction allows a higher-than-normal deduction for qualifying R&D expenditure carried out in Switzerland. The exact uplift depends on the canton, so the practical value of the relief should always be checked locally before a project is structured.
The patent box regime can reduce the tax burden on income derived from qualifying intellectual property. The relief is designed to keep valuable IP, development activity and commercialisation in Switzerland, particularly in sectors such as life sciences, medtech, fintech and advanced manufacturing.
Some cantons also offer tax holidays or substantial negotiated relief for new investments or major expansion projects. These are usually tied to regional development objectives and need to be agreed in advance.
2. Innosuisse funding
Innosuisse is the main federal body providing direct non-dilutive innovation support. It backs science-based innovation projects, often where a company is working with a research partner or developing a pre-market solution with commercial potential.
For start-ups, Innosuisse funding can cover a substantial share of eligible project costs, subject to co-funding requirements and eligibility rules. The agency also supports collaborative projects between companies and universities or public research bodies, helping to bridge the gap between research and market application.
Innosuisse also participates in programmes such as BRIDGE and supports Swiss involvement in international initiatives including Horizon Europe, Eurostars and EUREKA.
3. Research and venture support
The Swiss National Science Foundation is the main public funder of basic and application-oriented research. While its grants are not designed for commercialisation, they help build the research base that feeds into innovation and spin-out activity.
Switzerland also has a strong private funding market, especially in life sciences, health technology, deep tech and fintech. Venture Kick, university incubators and cantonal support programmes continue to play an important role in early-stage financing.
4. Practical view
Switzerland is best viewed as a highly competitive innovation location with support spread across several layers rather than concentrated in a single national scheme. For the right project, the combination of cantonal tax relief, federal grants and strong private capital can be very effective.
The main issue is local variation. Eligibility, deduction levels and relief caps differ by canton, so projects need to be structured carefully and checked against the relevant rules before they are presented as fundable.
We’re here to help. Contact us to discuss how ABGi Ireland can support your global innovation strategy.
